Llwytho...
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family, and GLP-1 receptor agonists (RAs) have been introduced as a new class of antidiabetic medications in the past decade. The benefits of GLP-1 RAs are derived from their pleiotropic effects, which include glucose-dependent...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Endocrinol Metab (Seoul) |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Korean Endocrine Society
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923410/ https://ncbi.nlm.nih.gov/pubmed/27118277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2016.31.2.258 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|